封面
市場調查報告書
商品編碼
2008129

數位生物製造市場:按類型、應用和地區分類

Digital Biomanufacturing Market, By Type, By Application, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到2026年,數位生物製造市場規模為28億美元,到2033年將達到87億美元。預計從2026年到2033年,該市場將以18.5%的複合年成長率成長。

分析範圍 分析詳情
基準年 2025 市場規模(2026 年) 28億美元
效能數據 2020-2024 預測期 2026-2033
預測期(2026-2033 年)複合年成長率 18.50% 預計金額(2033 年) 87億美元

數位化生物製造被視為數位化生物技術的進一步發展。它能夠基於預期產品品質和批次盈利等關鍵因素,實現即時製程最佳化。數位化生物製造軟體能夠提高設備的可靠性和可用性,同時降低維護成本。此外,它還能透過消除錯誤來提高效率。

數位化製造的優勢包括:

  • 增強的監控能力
  • 資料收集和處理
  • 連線功能
  • 電腦處理能力
  • 過程控制演算法
  • 自動化

市場動態

數位化生物製造有助於提高現有製程和設施的生產效率和穩定性。利用新興數位技術可以解決影響生物製造設施的關鍵挑戰。因此,向智慧製造的轉型和應用正在推動市場成長。數位化製造在價值鏈各個環節實現快速反應,進而降低維護成本,進而促進市場成長。數位技術實現的生產即時視覺化為關鍵決策提供更完善的信息,並加速創新。因此,數位化生物製造技術在製藥和生物製藥行業的應用日益廣泛。製造商正透過採用物聯網 (IoT) 和人工智慧 (AI) 等新技術來推動生產,這進一步強化了對數位化生物製造的需求。此外,製造自動化將為克服商業性成功所面臨的諸多挑戰提供重要機會。這將為近期市場成長創造巨大機會。

本報告的主要特點

  • 本報告對全球數位生物製造市場進行了詳細分析,包括預測期(2026-2033 年)的市場規模和複合年成長率,以 2025 年為基準年。
  • 此外,它還確定了每個細分市場的潛在商機,並描述了該市場中一系列有吸引力的投資提案。
  • 此外,它還提供了有關市場促進因素和限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
  • 本節根據以下參數,介紹全球數位生物製造市場的主要企業:公司概況、產品系列、主要亮點、財務表現和策略。
  • 本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、產品線更新、市場擴張和行銷策略做出明智的決策。
  • 《全球數位生物製造市場》報告面向該行業的眾多相關人員,包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
  • 相關人員可以透過分析全球數位生物製造市場中使用的各種策略矩陣來促進決策。

目錄

第1章:分析目標與假設

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因子
    • 市場機遇
  • 影響分析
  • 市場趨勢
  • 主要進展
  • 產品核准
  • 商業夥伴關係、企業合併
  • 監理情勢
  • PEST分析
  • 波特五力分析
  • 流行病學
  • 固體管道分析

第4章 數位生物製造市場:按類型分類(2026-2033 年)

  • 製造技術
  • 分析和過程控制技術
  • 其他

第5章:數位生物製造市場:按應用領域分類(2026-2033 年)

  • 生物製程最佳化
  • 生物製造過程的自動化和控制
  • 其他

第6章 數位生物製造市場:按地區分類(2026-2033 年)

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 其他亞太地區
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 北非
    • 中非
    • 南非

第7章 競爭情勢

  • 熱圖分析
  • 市佔率分析
  • 公司簡介
    • 3M
    • ABB
    • Cytiva
    • Siemens
    • immersciobio
    • Sanofi
    • BIOMERIEUX
    • Agilent Technologies, Inc.
    • GE Healthcare
    • Culture Biosciences

第8章

  • 參考
  • 分析方法
  • 關於 Coherent Market Insights
簡介目錄
Product Code: CMI5282

Digital Biomanufacturing Market is estimated to be valued at USD 2.8 Bn in 2026 and is expected to reach USD 8.7 Bn by 2033, growing at a compound annual growth rate (CAGR) of 18.5% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 2.8 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 18.50% 2033 Value Projection: USD 8.7 Bn

Digital biomanufacturing is consider as a potentially greater manifestation of digital biotechnology. Digital biomanufacturing offers real-time process optimization based on extremely valued factors like expected product quality and batch profitability. Digital biomanufacturing software improves asset dependability and availability while lowering maintenance costs. It helps to increase efficiency by elimating the errors.

Advantages of digital manufacturing includes:

  • Increased Monitoring
  • Data Collection and Handling
  • Connectivity
  • Computer power
  • Process control algorithms
  • Automation

Market Dynamics

Digital biomanufacturing helps to improve productivity and robustness of existing processes and facilities. Key issues affecting biomanufacturing facilities can be addressed with the use of new digital technologies. Thus, shift towards smart manufacturing, implementing smart manufacturing is driven the growth of market. Quicker turnaround across all levels of the value chain by digital manufacturing is leads to lowering maintenance costs. This in turn to drive the growth of market. Real-time production visibility made possible by digital technologies offers better information for making important decisions and accelerates innovation. Thus, digital biomanufacturing technology has increasingly use through pharmaceutical and biopharmaceutical industries. Manufacturers are implementing new technologies such as internate of things (IoT), artificial intelligence (AI) and among others to drive the production is strengthen the demand for digital biomanufacturing. Moreover, automation in manufacturing would provide substantial opportunities to overcome many of the challenges faced in commercial success. This in turn to create significant opportunity for market growth in near future

Key features of the study

  • This report provides an in-depth analysis of the global digital biomanufacturing market, provides market size (USD Bn), and compound annual growth rate (CAGR %) for the forecast period (2026-2033), considering 2025 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global digital biomanufacturing market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.
  • Key companies covered as a part of this study include 3M, ABB, Cytiva, Siemens, immersciobio, Sanofi, BIOMERIEUX, Agilent Technologies, Inc, GE Healthcare, Culture Biosciences
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global digital biomanufacturing market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global digital biomanufacturing market

Market Segmentation

  • By Type
    • Manufacturing Technologies
    • Analytical and Process Control Technologies
    • Others
  • By Application
    • Bioprocess Optimization
    • Biomanufacturing Process Automation and Control
    • Others
  • By Region
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East & Africa
    • GCC Countries
    • Israel
    • Rest of Middle East & Africa
  • Key Players
    • 3M
    • ABB
    • Cytiva
    • Siemens
    • immersciobio
    • Sanofi
    • BIOMERIEUX
    • Agilent Technologies, Inc
    • GE Healthcare
    • Culture Biosciences

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Application
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Product Approval
  • Collaboration/Merge/Acquisition
  • Regulatory Landscape
  • PEST Analysis
  • Porter's Five Forces Analysis
  • Epidemiology
  • Robust Pipeline Analysis

4. Digital Biomanufacturing Market, By Type, 2026 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2026- 2033
    • Segment Trends
  • Manufacturing Technologies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
  • Analytical and Process Control Technologies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)

5. Digital Biomanufacturing Market, By Application, 2026 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2026 - 2033
    • Segment Trends
  • Bioprocess Optimization
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
  • Biomanufacturing Process Automation and Control
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)

6. Digital Biomanufacturing Market, By Region, 2026 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2026-2033
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 - 2033, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

7. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
  • Company Profile
    • 3M
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • ABB
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Cytiva
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Siemens
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • immersciobio
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Sanofi
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • BIOMERIEUX
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Agilent Technologies, Inc.
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • GE Healthcare
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Culture Biosciences
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
  • Analyst Views

8. Section

  • References
  • Research Methodology
  • About Us